Recently, the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) released the 2022 Global Strategy for Diagnosis, Treatment and Prevention of Chronic Obstructive Pulmonary Disease (GOLD 2022), which provides the global doctors with the latest diagnosis and treatment plan for COPD. In the newly released report, new evidence and/or new suggestions were discussed on 10 topics. Among them, the GOLD 2022 guideline pointed out that patients with chronic obstructive pulmonary disease (COPD) should start lung rehabilitation treatment during hospitalization or within 4 weeks after discharge on the theme of 'the impact of acute exacerbation on the rehabilitation opportunity after admission'.

　　What is 'pulmonary rehabilitation'?

　　Pulmonary rehabilitation is defined as 'a comprehensive intervention and treatment program tailored for patients based on a comprehensive assessment of patients, including but not limited to exercise training, health education, nutritional support and psychological intervention. The goal is to improve the physical and psychological conditions of patients with chronic respiratory diseases, and to persist in improving health behaviors for a long time.'

　　The benefits of lung rehabilitation for patients with COPD are considerable!

　　The benefits of lung rehabilitation for patients with COPD are considerable!

　　·Pulmonary rehabilitation can improve dyspnea, health status and exercise tolerance of stable patients (Evidence A).

　　·Pulmonary rehabilitation reduced the hospitalization rate (≤ 4 weeks after admission) of patients with recent exacerbations (Evidence B).

　　·Pulmonary rehabilitation can reduce symptoms of anxiety and depression (Evidence A).

　　Pulmonary rehabilitation has been proved to be the most effective treatment strategy to improve shortness of breath, health status and exercise tolerance, as well as one of the most cost-effective treatment strategies.

　　Pulmonary rehabilitation is suitable for most COPD patients. Improvements in functional motor ability and health-related quality of life have been demonstrated at all levels of COPD severity, although the evidence is particularly strong in patients with moderate to severe disease.

　　A systematic evaluation report including 13 RCTs reported that the mortality and readmissions of patients who started pulmonary rehabilitation treatment during hospitalization or within 4 weeks after discharge decreased. The long-term impact on mortality was not statistically significant, but improvements in health-related quality of life and exercise capacity seemed to last at least 12 months.

　　Since pulmonary rehabilitation is an effective management strategy for COPD and has significant cost-benefit advantages compared with drug therapy, why has it not achieved significant results in practice?

　　The main reasons are that the medical staff do not pay enough attention, the patients do not have enough cognition, the patients have poor compliance in participating, and the implementation rate is low (lack of talents, lack of publicity and education, lack of relevant equipment, etc.).

　　Therefore, improving the cognition of medical staff and patients and strengthening rehabilitation education is the first step to carry out lung rehabilitation for patients with chronic obstructive pulmonary disease. The second step is to find ways to improve patients' compliance and equip relevant equipment.

　　Therefore, improving the cognition of medical staff and patients and strengthening rehabilitation education is the first step to carry out lung rehabilitation for patients with chronic obstructive pulmonary disease. The second step is to find ways to improve patients' compliance and equip relevant equipment.

　　Salt aerosol therapy is a new method for lung rehabilitation, and the Sinashu Rock Salt Aerosol Therapy Instrument is a trial equipment for lung rehabilitation.

　　Many clinical studies have shown that salt aerosol therapy, as a non drug complementary treatment, provides a new means and technology for lung rehabilitation, and plays an effective role in the prevention and treatment of respiratory diseases. It can help COPD patients reduce airway inflammation, enhance mucociliary swing activity, promote sputum discharge, prevent lung infection, so as to reduce clinical symptoms, reduce drug consumption, reduce hospital admissions, reduce acute incidence rate, and improve quality of life.

　　High accessibility: whether in public hospitals, grassroots medical and health institutions, health care institutions, or home rehabilitation, salt aerosol therapy can improve patients' participation enthusiasm and compliance, reduce economic costs and time costs, and save social resources.

　　High accessibility: whether in public hospitals, grassroots medical and health institutions, health care institutions, or home rehabilitation, salt aerosol therapy can improve patients' participation enthusiasm and compliance, reduce economic costs and time costs, and save social resources.

　　The Lancet, an international well-known medical journal, pointed out in the latest global rehabilitation demand report that rehabilitation should be integrated into the primary health care system, so as to improve its accessibility and benefit more patients.

　　China has a large population of patients with chronic obstructive pulmonary disease (COPD), and there are about 100 million patients with COPD at present, which requires low-cost and cost-effective management of COPD. Therefore, as an effective non drug treatment, pulmonary rehabilitation should be widely promoted and applied in grass-roots medical and health institutions. GOLD 2022 issued this time clearly points out that patients with chronic obstructive pulmonary disease should start lung rehabilitation treatment during hospitalization or within 4 weeks after discharge.

　　The Sinashu Rock Salt Aerosol Therapeutic Apparatus provides new means and technologies for the home rehabilitation of patients with COPD after discharge. At home, it can also assist drug therapy through natural respiration, significantly improve the immune status and lung function, and reduce the number of hospitalizations. If you or the people around you are COPD patients, if you want to prevent COPD, the Sinasu Salts Sol Therapeutic Apparatus will help you breathe healthily and stay away from COPD!